TMS may reduce depression symptoms when other treatments have not helped enough; response means substantial improvement, while remission means symptoms fall below clinical thresholds.
Does TMS work? Understanding response and remission
Transcranial magnetic stimulation, usually called TMS, is a non-invasive treatment that uses magnetic pulses to stimulate targeted areas of the brain. It is most often considered for major depressive disorder when previous treatments, such as antidepressant medicines or talking therapies, have not brought enough improvement.
TMS was cleared by the US Food and Drug Administration for major depressive disorder in 2008. In 2021, clearance also covered depression with comorbid anxiety. It is not a guaranteed treatment, and it does not work in the same way for everyone. However, published clinical trials and everyday clinical practice show that many people with depression experience a meaningful reduction in symptoms during a course of TMS.
When reading about TMS outcomes, two terms appear often: response and remission. They are related, but they do not mean the same thing.
What does “response” mean?
In TMS research, a response generally means that depressive symptoms have reduced substantially from where they were at the start of treatment.
This is usually assessed using a recognised depression questionnaire completed by the patient, clinician, or both. A person may be described as having responded when their score falls by around half from their baseline level. The exact measure and threshold can differ between studies, clinics and insurance requirements.
A response can be important even if someone does not feel completely well. For example, they may notice that:
- low mood is less intense or less frequent;
- getting out of bed feels more manageable;
- concentration and motivation begin to return;
- sleep or appetite improves;
- they can take part in work, family life or social activities more consistently;
- thoughts of hopelessness become less overwhelming.
In other words, response usually means clear and clinically meaningful improvement. Symptoms may still be present, and further treatment or support may still be needed.
What does “remission” mean?
Remission means that symptoms have reduced to a level where the person no longer meets the usual threshold for a depressive episode on the rating scale being used.
It does not necessarily mean that life is entirely stress-free, that every symptom has disappeared, or that depression can never return. Most people have difficult days from time to time. In clinical terms, remission means that the core symptoms of depression are absent or minimal enough that they are no longer causing the same level of illness and impairment.
A person in remission may still choose to continue medication, therapy, regular psychiatric follow-up, or other parts of a mental health care plan. Some may also discuss maintenance treatment with their clinician if symptoms return after an initially successful course.
Response and remission are therefore useful ways of describing outcomes, rather than promises about what any one person will experience.
What do published TMS trials report?
Published trials of TMS for depression generally find that a substantial proportion of participants improve, with some reaching remission. Results differ across studies because the people taking part, the treatment protocols, the definitions used and the follow-up periods are not identical.
The broad picture is that TMS can help many people with depression, particularly those who have not had enough benefit from earlier treatment. At the same time, not everyone responds, and some people improve only partly. A person may notice a gradual lift in symptoms without reaching remission by the end of the initial treatment course.
It is also worth looking carefully at what a reported result means. Studies may describe:
- Response rates, meaning substantial symptom improvement;
- Remission rates, meaning symptoms have fallen to a minimal level;
- Average score changes, which show how a group changed overall but do not predict an individual outcome;
- Short-term outcomes, measured at the end of treatment;
- Follow-up outcomes, showing whether improvements continued over time.
A result from a clinical trial should not be read as a personal forecast. Trials provide useful evidence about groups of people. Your own likelihood of benefit depends on your health history, diagnosis, treatment plan and circumstances.
Why individual results vary
Depression is not one uniform condition. Two people with the same diagnosis may have different symptoms, different causes or triggers, and different treatment histories. This is one reason TMS results vary.
Factors that may affect outcomes include the severity and duration of depression, whether anxiety or other mental health conditions are also present, and how many previous treatments have been tried. Physical health, sleep, alcohol or substance use, medication changes, major life stress and access to ongoing support can also matter.
The TMS treatment itself is tailored in certain ways. The clinician will decide whether TMS is appropriate, select a protocol, identify the treatment area and adjust the stimulation intensity to a suitable level. Different FDA-cleared devices and treatment approaches exist, and a clinician can explain the approach offered at a particular service.
Attendance matters too. A standard TMS course is commonly around 36 weekday sessions over roughly six to nine weeks. It can be difficult to judge the full benefit if treatment is interrupted repeatedly, although illness, transport difficulties, work and caring responsibilities can make regular attendance challenging.
Improvement is often gradual. Some people notice changes early, while others report a clearer difference later in the course. If you are considering TMS, it can be helpful to ask how your clinic tracks symptoms and when progress will be reviewed.
What if TMS does not lead to remission?
Not reaching remission does not mean treatment has been pointless. A meaningful response may still reduce distress and help someone engage more fully with therapy, daily routines, relationships or work.
If symptoms have not improved enough, the treating clinician may review several questions: whether the diagnosis remains the best explanation for the symptoms, whether there have been changes in medication or sleep, whether another treatment should be considered, and whether a different ongoing care plan is needed.
TMS should be part of a wider clinical conversation, not treated as an isolated decision. Your prescriber or mental health professional can consider previous treatments, current medicines, medical history and safety factors. TMS is generally well tolerated; common side effects include temporary scalp discomfort and headache. Seizure is a rare risk, which is one reason screening and clinical supervision are important.
Finding TMS care in Alabama
TMS Therapy Alabama currently lists 46 published clinics across the state directory. Listings include services in Birmingham, Tuscaloosa, Dothan, Decatur, Huntsville, Montgomery, Mobile and other Alabama communities.
Practical arrangements can affect whether a course is realistic. Before booking an assessment, consider asking about appointment times, how progress is measured, who provides follow-up care, and whether the clinic can coordinate with your existing prescriber or therapist.
Insurance cover depends on your individual plan and clinical circumstances. Carriers commonly seen in Alabama include Blue Cross and Blue Shield of Alabama, UnitedHealthcare, Aetna, Cigna, Humana, Viva Health, Alabama Medicaid and Medicare. A clinic can explain its own billing process, but it is sensible to confirm eligibility, referral requirements and likely out-of-pocket costs directly with your insurer.
Getting help in Alabama
Use the TMS Therapy Alabama clinic listings to compare published local options, read the insurance guide before contacting providers, and use the contact page if you need help navigating the directory.
This article is educational information, not medical advice.
This page is informational and is not medical advice.